Inventor · disambiguated record
David Krisky
Also filed as: KRISKY DAVID · KRISKY DAVID M
10 granted patents·9 pending applications·143 citations·filing 1997–2024
89Inventor score
Files withUNIV PITTSBURGH5PERIPHAGEN INC4UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION3UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION3CANDEL THERAPEUTICS INC1
Top patents by PatentIndex Score
19 records- 0194US7531167B2Herpes simplex virus vectorUNIV PITTSBURGH·Filed 2007·Granted May 12, 2009·31 cites·14 claims
- 0290US8957036B2Targeted delivery of glycine receptors to excitable cellsCASCIO MICHAEL·Filed 2011·Granted Feb 17, 2015·19 cites·14 claims
- 0387US10174341B2Non-toxic HSV vectors for efficient gene delivery applications and complementing cells for their productionUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2014·Granted Jan 8, 2019·13 cites·13 claims
- 0485US5998174AMultigene vectorsUNIV PITTSBURGH·Filed 1997·Granted Dec 7, 1999·71 cites·11 claims
- 0583US2025109411A1Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their productionUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2024·Application pending·0 cites
- 0680US11753653B2High-transducing HSV vectorsPERIPHAGEN INC·Filed 2017·Granted Sep 12, 2023·2 cites·14 claims
- 0777US12275949B2High-transducing HSV vectorsPERIPHAGEN INC·Filed 2023·Granted Apr 15, 2025·0 cites·14 claims
- 0876US10799560B2HSV vectors for delivery of NT3 and treatment of CIPNPERIPHAGEN INC·Filed 2017·Granted Oct 13, 2020·3 cites·30 claims
- 0975US8309349B2Cell lineGLORIOSO JOSEPH C·Filed 2009·Granted Nov 13, 2012·3 cites·3 claims
- 1072US2022213508A1Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their productionUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 1171US2008289058A1Targeted delivery of glycine receptors to excitable cellsUNIV PITTSBURGH·Filed 2008·Application pending·0 cites
- 1270US11725038B2Targeted delivery of glycine receptors to excitable cellsUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2020·Granted Aug 15, 2023·0 cites·13 claims
- 1369US10696727B2Targeted delivery of glycine receptors to excitable cellsUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2014·Granted Jun 30, 2020·1 cites·6 claims
- 1460US2014256801A1Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury painUNIV PITTSBURGH·Filed 2014·Application pending·0 cites
- 1557US2019276845A1Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their productionUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2018·Application pending·0 cites
- 1656US2025270588A1Compositions and methods for viral vectorsCANDEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1756US2007207124A1Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury painDEPT OF VETERANS AFFAIRS 024·Filed 2005·Application pending·0 cites
- 1854US2025263741A1Hsv vectorsPERIPHAGEN INC·Filed 2022·Application pending·0 cites
- 1950US2004043488A1Adeno-associated viral gene-transfer vector systemUNIV PITTSBURGH·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Krisky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →